Log In
Print this Print this

Engineered Skin Substitute (ESS) (PermaDerm)

  Manage Alerts
Collapse Summary General Information
Company Amarantus BioScience Holdings Inc.
DescriptionAutologous tissue-engineered skin substitute
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Organ/tissue engineering
Latest Stage of DevelopmentPhase II
Standard IndicationBurns
Indication DetailsTreat pediatric severe burns; Treat severe burns in adults
Regulatory Designation U.S. - Orphan Drug (Treat severe burns in adults)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today